Domain unfolding of monoclonal antibody fragments revealed by non-reducing SDS-PAGE

[1]  A. Norman,et al.  Unfolding of IgG domains detected by non-reducing SDS-PAGE. , 2018, Biochemical and biophysical research communications.

[2]  A. Norman,et al.  Characterization of a recombinant humanized anti-cocaine monoclonal antibody produced from multiple clones for the selection of a master cell bank candidate. , 2017, Biochemical and biophysical research communications.

[3]  A. Norman,et al.  Selective disulfide reduction for labeling and enhancement of Fab antibody fragments. , 2016, Biochemical and biophysical research communications.

[4]  A. Norman,et al.  Structural characterization of expressed monoclonal antibodies by single sample mass spectral analysis after IdeS proteolysis. , 2016, Biochemical and biophysical research communications.

[5]  A. Norman,et al.  Characterization of a recombinant humanized anti-cocaine monoclonal antibody and its Fab fragment , 2015, Human vaccines & immunotherapeutics.

[6]  A. Norman,et al.  A Recombinant Humanized Anti-Cocaine Monoclonal Antibody Inhibits the Distribution of Cocaine to the Brain in Rats , 2014, Drug Metabolism and Disposition.

[7]  J. Rotrosen,et al.  Vaccine for cocaine dependence: a randomized double-blind placebo-controlled efficacy trial. , 2014, Drug and alcohol dependence.

[8]  Christopher M Johnson,et al.  Differential scanning calorimetry as a tool for protein folding and stability. , 2013, Archives of biochemistry and biophysics.

[9]  A. Norman,et al.  Predicting the clinical efficacy and potential adverse effects of a humanized anticocaine monoclonal antibody. , 2012, Immunotherapy.

[10]  Bridget A. Martell,et al.  Cocaine vaccine for the treatment of cocaine dependence in methadone-maintained patients: a randomized, double-blind, placebo-controlled efficacy trial. , 2009, Archives of general psychiatry.

[11]  A. Fisher,et al.  Peroxiredoxin-6 protects against mitochondrial dysfunction and liver injury during ischemia-reperfusion in mice. , 2009, American journal of physiology. Gastrointestinal and liver physiology.

[12]  S. Demarest,et al.  A broad range of Fab stabilities within a host of therapeutic IgGs. , 2007, Biochemical and biophysical research communications.

[13]  W. Ling,et al.  Medications development: successes and challenges. , 2005, Pharmacology & therapeutics.

[14]  S. M. Owens,et al.  Immunotherapy for the treatment of drug abuse. , 2005, Pharmacology & therapeutics.

[15]  Bridget A. Martell,et al.  Vaccine Pharmacotherapy for the Treatment of Cocaine Dependence , 2005, Biological Psychiatry.

[16]  S. Demarest,et al.  Optimization of the antibody C(H)3 domain by residue frequency analysis of IgG sequences. , 2004, Journal of molecular biology.

[17]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.

[18]  A. Norman,et al.  Three-dimensional quantitative structure-activity relationship modeling of cocaine binding by a novel human monoclonal antibody. , 2004, Journal of medicinal chemistry.